Precision Oncology: AI Startup Lunit to Present 6 Studies at AACR 2026

Algorithms are penetrating deeper into clinical practice. On April 18, 2026, the South Korean AI developer Lunit announced the presentation of six scientific papers at the upcoming AACR 2026 conference in San Diego.

The focus of the research has shifted from abstract image analysis to precision oncology. Lunit's algorithms are used to discover AI-driven biomarkers and conduct detailed analysis of the tumor microenvironment. Such developments are critical for personalized medicine, allowing oncologists to accurately predict a patient's response to immunotherapy. The integration of such solutions elevates AI to the status of a fully-fledged assistant, saving lives on the level of evidence-based medicine.

Source: Lunit / PR Newswire